The Nano4 project takes fast, reliable and low-cost molecular point of care (POC) diagnostic tools down to the nano-scale, offering better healthcare outcomes for patients.
Medics working in migratory hotspots, in countries with low laboratory infrastructure or in other demanding situations often need to be able to screen large populations quickly, in a non-centralised manner. Patients who would be more comfortable not having to travel far to be screened, and those with conditions which demand swift action, such as suspected chronic myeloid leukaemia, would also benefit.
The EU-funded Nano4 project has developed a fast, accurate, low-cost, point-of-care diagnostic for certain viruses, pathogens and cancer-types. The technology will help healthcare decision-makers to act quickly, save lives, reduce pain and avoid mistakes. It could even prevent epidemics.
Image Credit: Nano4 Global
News This Week
In April, blood clots emerged as one of the many mysterious symptoms attributed to Covid-19, a disease that had initially been thought to largely affect the lungs in the form of pneumonia. Quickly after came [...]
Scientists from the University of Maryland School of Medicine (UMSOM) developed an experimental diagnostic test for COVID-19 that can visually detect the presence of the virus in 10 minutes. It uses a simple assay [...]
Rheumatologists at the University of Alberta are flagging similarities between the deaths of some COVID-19 patients and those with rheumatic illnesses, and are testing proven rheumatic treatments to see whether they help against [...]
Next-gen nano technologies that can prevent infection and diagnose disease are set to transform the medical industry as this important UniSA research is awarded more than $2 million dollars under the National Health and [...]
In late December last year, Dr. Li Wenliang began warning officials about a novel coronavirus in Wuhan, China, but was silenced by the police before tragically succumbing to the disease two months later. Meanwhile, [...]
Almost 10 weeks into the pandemic, COVID-19 is continuing to surprise and baffle health experts. In fact, experts' picture of exactly how COVID-19 might play out in the body is now quite different to [...]
EPFL scientists have developed a new computational approach to create artificial proteins, which showed promising results in vivo as functional vaccines. This approach opens the possibility to engineer safer and more effective vaccines. Vaccines [...]
A group of tiny RNA that should attack the virus causing COVID-19 when it tries to infect the body are diminished with age and chronic health problems, a decrease that likely helps explain why [...]